Finance

Beta
Lists
ALOPM:EPA
Oncodesign Precision Medicine Opm SA
€0.34
-8.11%
(-0.030) 1D
Jun 5, 5:35:06 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALOPM...
Open
€0.37
High
€0.38
Low
€0.34
Mkt. cap
6.88M
Avg. vol.
19.76K
Volume
30.85K
P/E ratio
1.14
52-wk high
€0.92
52-wk low
€0.28
EPS
€0.30
Shares outstanding
19.14M
No. of employees
13
Open
€0.37
High
€0.38
Low
€0.34
Mkt. cap
6.88M
Avg. vol.
19.76K
Volume
30.85K
P/E ratio
1.14
52-wk high
€0.92
52-wk low
€0.28
EPS
€0.30
Shares outstanding
19.14M
No. of employees
13
News stories
From sources across the web
About Oncodesign Precision Medicine Opm SA
CEO-
Employees13
Founded1995
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
371.41K
371.41K
535.02K
535.02K
Cost of goods sold
-5.38M
-5.38M
1.91M
1.91M
Cost of revenue
-5.38M
-5.38M
1.91M
1.91M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
753.34K
753.34K
543.53K
543.53K
Operating expense
864.67K
864.67K
657.93K
657.93K
Total operating expenses
-4.51M
-4.51M
2.57M
2.57M
Operating income
4.89M
4.89M
-2.03M
-2.03M
Other non operating income
-1.00
-1.00
-9.56K
-9.56K
EBT including unusual items
4.77M
4.77M
-2.01M
-2.01M
EBT excluding unusual items
4.79M
4.79M
-2.01M
-2.01M
Income tax expense
-155.35K
-155.35K
172.17K
172.17K
Effective tax rate
-3.26%
-3.26%
-8.56%
-8.56%
Other operating expenses
28.11K
28.11K
27.67K
27.67K
Net income
4.92M
4.92M
-2.18M
-2.18M
Net profit margin
1,325.44%
1,325.44%
-408.02%
-408.02%
Earnings per share
-
-
-
-
Interest and investment income
7.79K
7.79K
29.55K
29.55K
Interest expense
-105.71K
-105.71K
-
-
Net interest expenses
-97.92K
-97.92K
29.55K
29.55K
Depreciation and amortization charges
83.22K
83.22K
86.72K
86.72K
EBITDA
4.97M
4.97M
-1.95M
-1.95M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more